CaLecPred
CaLecPred predicts cancerlectins from protein sequence data to enable identification of lectins involved in tumor cell differentiation.
Key Features:
- Sequence-based classification: Uses g-gap dipeptide composition derived from protein sequences to represent candidate lectins.
- Feature selection: Applies analysis of variance (ANOVA) to select an optimal subset of g-gap dipeptide features.
- Validation and performance: Employs jackknife cross-validation and achieved a jackknife accuracy of 75.19%.
- Prediction objective: Distinguishes cancerlectins from non-cancerlectins based on sequence-derived features.
Scientific Applications:
- Cancerlectin identification: Enables computational identification of cancerlectins from sequence data to support investigation of lectins implicated in tumor cell differentiation.
- Experimental prioritization: Provides predictions to guide and prioritize experimental validation of candidate cancerlectins.
- Resource-efficient screening: Serves as a computational alternative to wet-experimental methods, helping to reduce time and financial costs for cancerlectin studies.
- Therapeutic research: Supports studies of cancerlectin roles that may inform therapeutic targeting strategies.
Methodology:
Represents sequences using g-gap dipeptide composition, selects features with analysis of variance (ANOVA), and evaluates model performance via jackknife cross-validation.
Topics
Details
- Tool Type:
- api
- Added:
- 8/3/2017
- Last Updated:
- 11/25/2024
Operations
Publications
Lin H, Liu W, He J, Liu X, Ding H, Chen W. Predicting cancerlectins by the optimal g-gap dipeptides. Scientific Reports. 2015;5(1). doi:10.1038/srep16964. PMID:26648527. PMCID:PMC4673586.